MicroRNA-195 Inhibits the Proliferation of Human Glioma Cells by Directly Targeting Cyclin D1 and Cyclin E1

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Hui, Wang ^a   Yuntao, Lu ^b   Lun, Luo ^a   WenSheng, Li ^a   ChaoFeng, Liang ^a   HaiYong, He ^a   Yueyang, Ba ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b FIRST MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN E; CYCLIN E1; CYCLINE; MESSENGER RNA; MICRORNA; MICRORNA 195; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; ASTROCYTE; CANCER CELL CULTURE; CARCINOGENICITY; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; OPEN READING FRAME; PROTEIN PHOSPHORYLATION; TUMOR VOLUME; UPREGULATION;

3' UNTRANSLATED REGIONS; ANIMALS; ASTROCYTES; BASE SEQUENCE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN D1; CYCLIN E; DOWN-REGULATION; GLIOMA; HUMANS; MICE; MICE, INBRED BALB C; MICRORNAS; ONCOGENE PROTEINS; PROLIFERATING CELL NUCLEAR ANTIGEN; TUMOR MARKERS, BIOLOGICAL;

EID: 84873871667     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054932     Document Type: Article

References (52)

1. Oliver Gautschi, Daniel Ratschiller, Mathias Gugger, (2007) Cyclin D1 in non-small cell lung cancer: A key driver of malignant transformation. Lung Cancer 55: 1-14.
2. D Resnitzky, M Gossen, H Bujard, S I Reed, (1994) Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system.Mol Cell Biol. 14: 1669-1679.
3. Lew DJ, Dulić V, Reed SI, (1991) Isolation of three novel human cyclins by rescue of G1 cyclin (Cln) function in yeast. Cell 66: 1197-1206.
4. Matsushime H, Roussel MF, Ashmun RA, Sherr CJ, (1991) Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 65: 701-713.
5. Motokura T, Bloom T, Kim HG, Jüppner H, Ruderman JV, et al. (1991) A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature 350: 512-515.
6. Gloria Dimco, Richard A Knight, David S Latchman, (2010) STAT1 interacts directly with cyclin D1/Cdk4 and mediates cell cycle arrest. Cell Cycle 9: 4638-4649.
7. Italiano A, Bianchini L, Gjernes E, Keslair F, Ranchere-Vince D, et al. (2009) Clinical and Biological Significance of CDK4 Amplification in Well-Differentiated and Dedifferentiated Liposarcomas.Clin Cancer Res. 15: 5696-5703.
8. Wang J, Wang Q, Cui Y, Liu ZY, Zhao W, et al. (2012) Knockdown of cyclin D1 inhibits proliferation, induces apoptosis, and attenuates the invasive capacity of human glioblastoma cells. J Neurooncol 106: 473-484.
9. Fu M, Wang C, Li Z, Sakamaki T, Pestell RG, (2004) Minireview: Cyclin D1: normal and abnormal functions. Endocrinology 145: 5439-5447.
10. Charles H Spruck, Kwang-Ai Won, Steven I Reed, (1999) Deregulated cyclin E induces chromosome instability. Nature 401: 297-300.
11. Sergei B Koralov, Stefan A Muljo, Gunther R Galler, Azra Krek, Tirtha Chakraborty, et al. (2008) Dicer Ablation Affects Antibody Diversity and CellSurvival in the B Lymphocyte Lineage. Cell 132: 860-874.
12. Weis SM, Cheresh DA, (2011) Tumor angiogenesis: molecular pathways and therapeutic targets. Nature Medicine 17: 1359-1370.
13. Gillett C, Smith P, Gregory W, Richards M, Millis R, et al. (1996) Cyclin D1 and prognosis in human breast cancer. Int J Cancer 69: 92-99.
14. Hall M, Peters G, (1996) Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv Cancer Res 68: 67-108.
15. Molenaar JJ, Ebus ME, Koster J, van SP, van Noesel CJ, et al. (2008) Cyclin D1 and CDK4 activity contribute to the undifferentiated phenotype in neuroblastoma. Cancer Res 68: 2599-2609.
16. Akli S, Keyomarsi K, (2003) Cyclin E and its low molecular weight forms in human cancer and as targets for cancer therapy. Cancer Biol Ther 2: 38-47.
17. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, et al. (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996.
18. Holland E C, (2001) Gliomagenesis: genetic alterations and mouse models. Nat Rev Genet 2: 120-129.
19. Reardon D A, Rich J N, Friedman H S, Bigner D D, (2006) Recent advances in the treatment of malignant astrocytoma. J Clin Oncol 24: 1253-1265.
20. Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, et al. (2001) Malignant glioma: genetics and biology of a grave matter. Genes Dev 15: 1311-1333.
21. Sanai N, Alvarez-Buylla A, Berger M S, (2005) Neural stem cells and the origin of gliomas. N Engl J Med 353: 811-822.
22. Zhu Y, Parada L F, (2002) The molecular and genetic basis of neurological tumours. Nat Rev Cancer 2: 616-626.
23. Jansen M, de Witt Hamer PC, Witmer AN, Troost D, van Noorden CJ, (2004) Current perspectives on antiangiogenesis strategies in the treatment of malignant gliomas. Brain Res Brain Res Rev 45: 143-163.
24. Sherer H J, (1940) The forms of growth in glioma and their practical significance. Brain 63: 1-35.
25. Hoelzinger D B, Demuth T, Berens M E, (2007) Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment. J Natl Cancer Inst 99: 1583-1593.
26. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
27. Ambros V, (2004) The functions of animal microRNAs. Nature 431: 350-355.
28. Calin G A, Croce C M, (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866.
29. Gregory R I, Shiekhattar R, (2005) MicroRNA biogenesis and cancer. Cancer Res 65: 3509-3512.
30. Ruvkun G, (2006) Clarifications on miRNA and cancer. Science 311: 36-37.
31. Esquela-Kerscher A, Slack F J, (2006) Oncomirs- microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269.
32. Li J, Zhang N, Song LB, Liao WT, Jiang LL, et al. (2008) Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival. Clin Cancer Res 14: 319-326.
33. Arato-Ohshima T, Sawa H, (1999) Over-expression of cyclin D1 induces glioma invasion by increasing matrix metalloproteinase activity and cell motility. Int J Cancer 83: 387-392.
34. Chakravarti A, Delaney MA, Noll E, Black PM, Loeffler JS, et al. (2001) Prognostic and pathologic significance of quantitative protein expression profiling in human gliomas. Clin Cancer Res 7: 2387-2395.
35. Liu C, Tu Y, Sun X, Jiang J, Jin X, et al. (2011) Wnt/beta-Catenin pathway in human glioma: expression pattern and clinical/prognostic correlations. Clin Exp Med 11: 105-112.
36. JunYu Wang, Qi Wang, Yong Cui, (2011) Knockdown of cyclin D1 inhibits proliferation, induces apoptosis, and attenuates the invasive capacity of human glioblastoma cells. 106: 473-484.
37. Sutherland RL, Musgrove EA, (2004) Cyclins and breast cancer. J Mammary Gland Biol Neoplasia. 9: 95-104.
38. Shariat SF, Ashfaq R, Sagalowsky AI, Lotan Y, (2006) Correlation of cyclin D1 and E1 expression with bladder cancer presence, invasion, progression, and metastasis. Hum Pathol 37: 1568-1576.
39. Johnson DG, Walker CL, (1999) Cyclins and cell cycle checkpoints. Annu Rev Pharmacol Toxicol 39: 295-312.
40. Schwartz GK, Shah MA, (2005) Targeting the cell cycle: a new approach to cancer therapy. J Clin Oncol 23: 9408-9421.
41. Brehm A, Miska EA, McCance DJ, Reid JL, Bannister AJ, et al. (1998) Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391: 597-601.
42. Magnaghi-Jaulin L, Groisman R, Naguibneva I, Robin P, Lorain S, et al. (1998) Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391: 601-605.
43. DePinho RA. (1998) Transcriptional repression. The cancer-chromatin connection. Nature 391: 533, 535-536.
44. Xu T, Zhu Y, Xiong Y, Ge YY, Yun JP, et al. (2009) MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells. Hepatology. 50: 113-121.
45. Guo J, Miao Y, Xiao B, Huan R, Jiang Z, et al. (2009) Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hepatol. 24: 652-657.
46. Heneghan HM, Miller N, Lowery AJ, Sweeney KJ, Newell J, et al. (2010) Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg 251: 499-505.
47. Zhang QQ, Xu H, Huang MB, Ma LM, Huang QJ, et al. (2012) MicroRNA-195 plays a tumor-suppressor role in human glioblastoma cells by targeting signaling pathways involved in cellular proliferation and invasion. Neuro Oncol. 14(3): 278-287.
48. Trompeter HI, Abbad H, Iwaniuk KM, Hafner M, Renwick N, et al. (2011) MicroRNAs MiR-17, MiR-20a, and MiR-106b act in concert to modulate E2F activity on cell cycle arrest during neuronal lineage differentiation of USSC. PLoS One 6: e16138.
49. Zhang W, Kong G, Zhang J, Wang T, Ye L, et al. (2012) MicroRNA-520b inhibits growth of hepatoma cells by targeting MEKK2 and cyclin D1. PLoS One 7: e31450.
50. Ding DP, Chen ZL, Zhao XH, Wang JW, Sun J, et al. (2011) miR-29c induces cell cycle arrest in esophageal squamous cell carcinoma by modulating cyclin E expression. Carcinogenesis. 32: 1025-1032.
51. Xu T, Zhu Y, Xiong Y, Ge YY, Yun JP, et al. (2009) MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells. Hepatology. 50(1): 113-121.
52. Sekiya Y, Ogawa T, Iizuka M, Yoshizato K, Ikeda K, et al. (2011) Down-regulation of cyclin E1 expression by microRNA-195 accounts for interferon-β-induced inhibition of hepatic stellate cell proliferation. J Cell Physiol. 226(10): 2535-2542.